The goal: detecting cancer before there are signs or symptoms. Harbinger Health was founded to tackle this challenge and fundamentally change cancer care for everyone. https://hrbn.gr/3Nqv4qL
关于我们
At Harbinger Health, our mission is to change the cancer paradigm by taking a proactive approach to cancer detection and prevention. We envision a future where cancer is no longer a life-altering event, but a routine health problem that can be addressed with early intervention. To achieve this, we have developed proprietary solutions for cancer pre-emption, starting with blood-based tests that can detect cancer before it even becomes visible. By identifying biological programs that are the root cause of cancer, we can enable early-stage and pre-disease identification, leading to truly personalized and effective cancer care for everyone. With Harbinger Health leading the way, we believe that a cancer-free future is not only possible but within reach, for everyone.
- 网站
-
https://www.harbinger-health.com
Harbinger Health的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Cambridge，MA
- 类型
- 私人持股
- 创立
- 2021
- 领域
- MCED、Cancer、cancer prevention、cancer education、oncology和early cancer detection
地点
-
主要
获取路线
25 Spinelli Pl
US，MA，Cambridge
Harbinger Health员工
-
Ajit Singh
Partner at Artiman Ventures; Board Member at Artiman companies; Independent Director; former CEO of BioImagene (acquired by Roche); former CEO of…
-
Mark Stevenson
Senior Partner at Flagship Pioneering, Life Sciences Board Member and Investor | Former EVP & COO at Thermo Fisher Scientific
-
Vincent Lozada, CFA
Chief Financial Officer, Harbinger Health
-
Gisela A. Paulsen, MPharm
Global Leadership | Life Sciences | Product Development | Product Life Cycle | Operations | Scaling | Commercial P&L | Compliance | Change Management…
动态
-
Preemptive Health is a new field, distinct from today’s medicine. And we're proud to be a part of it with our parent company Flagship Pioneering. Learn more about it here. https://hrbn.gr/4eJA6La
-
Two different lived experiences. One common connection. RuQuan and Steve talk about the intentionality of the impact they each want to make in the world and places where trust breaks down in healthcare. https://hrbn.gr/3YaqRwk
The TLC Project
tlc-project.com
-
How are we developing proprietary solutions for the future of cancer pre-emption? By starting with blood-based tests that enable the detection of early cancer. See how we're combining unique insights into the biology of cancer’s origin with artificial intelligence and the latest screening technologies. https://hrbn.gr/48aRSnT
-
-
Effective cancer screening tests don't just detect cancer early, they improve outcomes. https://hrbn.gr/3BniAxr
What Cancer Screening Tests Check for Cancer?
cancer.gov
-
At Harbinger Health, we intend to lead in shaping the future – one where people can live cancer-free for longer, adding years to life and life to years. https://hrbn.gr/4gHUf5F
-
-
A new study shows that many kinds of cancer pull an unusual card to support their growth: DNA left over from ancient viruses. https://hrbn.gr/3Y1g8Wi
DNA from Ancient Retrovirus Helps Cancer Grow
cancer.gov
-
Harbinger Health CEO, Steve Hahn talks about the need to focus on what’s good and right and needed when developing healthcare technology in this episode of the TLC Project. Join the conversation here. https://hrbn.gr/47PA8OJ
-
Will you be attending LEAP TA: Life Sciences 2024 later this month? Ahead of the big event, our Associate Director of Talent Acquisition, Conor Sullivan chatted with LEAP HR. Hear what he had to say here. https://hrbn.gr/3ZOhjJV
-
Predictive values help answer a critical question: Given a test result, what's the likelihood that it's accurate? At Harbinger Health, we're making it our mission to provide tests that deliver reliable results for better patient outcomes. https://hrbn.gr/3Y5g9IT
-